Verry, Camille https://orcid.org/0000-0002-9362-7624
Vincendeau, Sébastien
Massetti, Marc
Blachier, Martin
Vimont, Alexandre
Bazil, Marie-Laure
Bernardini, Pauline
Pettré, Ségolène
Timsit, Marc-Olivier
Clinical trials referenced in this document:
Documents that mention this clinical trial
Pattern of Clinical Progression Until Metastatic Castration-Resistant Prostate Cancer: An Epidemiological Study from the European Prostate Cancer Registry
https://doi.org/10.1007/s11523-022-00899-6
Funding for this research was provided by:
Janssen Research and Development
Article History
Accepted: 30 June 2022
First Online: 16 July 2022
Declarations
:
: The Prostate Cancer Registry (PCR) secondary analyses were funded by Janssen-Cilag France. Janssen Cilag, France contributed to the study design, the collection, analysis, and interpretation of data, the writing of the report, and the decision to submit the paper for publication.
: Camille Verry, Sébastien Vincendeau, and Marc-Olivier Timsit received fees from Janssen-Cilag to participate in the conception, design, interpretations, and the writing of these secondary analyses presented in this manuscript. Marie-Laure Bazil, Pauline Bernardini, and Ségolène Pettré are employees of Janssen-Cilag, Issy les Moulineaux, France. Marc Massetti, Martin Blachier, and Alexandre Vimont are employees of Public Health Expertise which was contracted by Janssen-Cilag, France to perform the Prostate Cancer Registry (PCR) secondary analyses and participate in the writing of the manuscript.
: The Prostate Cancer Registry (PCR) was approved by the ethics committees of every country that participated. The study was conducted in accordance with the Declaration of Helsinki.
: All patients provided written informed consent.
: The data-sharing policy of Janssen Pharmaceutical Companies of Johnson & Johnson is available at . As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at https ://yoda.yale.edu.
: All authors contributed to the Prostate Cancer Registry (PCR) secondary analyses including study conception, design, and writing of the manuscript. All authors read and approved the final manuscript. Public Health Expertise which was contracted by J-C, France to perform the Prostate Cancer Registry (PCR) secondary registry analyses and participate in the writing of the manuscript. The funder of the study (J-C) had a role in study design, data collection, data analysis, data interpretation (in collaboration with all authors), and writing of the manuscript. The corresponding author had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.